CAPTRUST Financial Advisors’s AIM ImmunoTech AIM Stock Holding History
Bought
Maintained
Sold
Other funds holding AIM
CB
HI
HI
DB
CAPTRUST Financial Advisors's AIM Position: Q2 2025 in Review
CAPTRUST Financial Advisors sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 200 shares — an estimated $2.45K sold.
CAPTRUST Financial Advisors first reported a position in AIM in Q4 2020 and held it in 17 quarters. The position peaked at $43K in Q2 2021. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.
- CAPTRUST Financial Advisors reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
- CAPTRUST Financial Advisors sold 200 AIM ImmunoTech shares in Q2 2025, an estimated $2.45K.
- CAPTRUST Financial Advisors first reported a position in AIM ImmunoTech in Q4 2020 and held it in 17 quarters.
- CAPTRUST Financial Advisors's AIM ImmunoTech position peaked at $43K in Q2 2021.
- 12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.
Based on CAPTRUST Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.